“We are honored to support such an important cause and area of research. Treatment for HIV AIDS has come far, which means a cure is possible. We need to keep pushing for a cure and a future where no one suffers from this disease,” notes Content Science CEO Colleen Jones.
The AIDS Vaccine 200 brings together teams of bike riders of all levels who garner thousands of donations for cycling from Atlanta to Athens and back over the course of two days. The start and finish of the double century draw hundreds of enthusiastic supporters.
“I love that the AIDS Vaccine 200 brings together the power of scientific research and the power of community. This event and its cause are unstoppable, ” Jones explains.
To learn more about AIDS Vaccine 200 and how to support it, visit www.av200.org.
About Content Science
Content Science is an award-winning content intelligence and strategy company founded by Colleen Jones, author of “Clout: The Art and Science of Influential Web Content.” Based in Atlanta, Georgia, Content Science has advised clients including Fortune 500 companies, startups, institutions, and government agencies since 2010. The firm also owns the content intelligence product ContentWRX, runs Content Science Academy, and publishes the online magazine Content Science Review.
For media inquiries, please contact us at 770-999-0697 or send us a note.